Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Presenter: Daniel Snyder

March 05, 2024

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

Presentation

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

Presenter: Gregg W. Stone

April 14, 2015

Presentation Cardiovascular Interventions 2014

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

Presenter: David P. Faxon

October 23, 2014

Presentation

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Presenter: M. V. Madhavan

August 27, 2014

Presentation

Use of the REG1 Anticoagulation System in Patients with ACS Undergoing PCI

Presenter: Thomas J. Povsic

June 27, 2014

Presentation TCT 2013

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Presenter: Harvey White

October 31, 2013

Presentation TCT 2013

Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer?

Presenter: Peter Clemmensen

October 31, 2013

Presentation TCT 2013

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT Mediterranean 2012

Anticoagulation in ACS: Role of Bivalirudin

Presenter: Gregg W. Stone

May 04, 2012

Advertisement

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Use of the REG1 Anticoagulation System in Patients with ACS Undergoing PCI

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer?

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Anticoagulation in ACS: Role of Bivalirudin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content